Ratings by H.C. Wainwright (Swayampakula Ramakanth)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/23/2021 Trillium Therapeutics TRIL Downgrade Neutral
(Buy)
6.09
(17.34)
184.73% Details
8/16/2021 Sesen Bio, Inc SESN Downgrade Neutral
(Buy)
2.11
(0.91)
-56.87% Details
7/12/2021 AVEO Pharmaceuticals AVEO Maintain Buy
(N/A)
 
 
  Details
7/6/2021 Janux Therapeutics JANX New Coverage Buy
(N/A)
25.40
(27.39)
7.83% Details
6/23/2021 Corcept Therapeutics CORT Maintain Buy
(N/A)
 
 
  Details
6/17/2021 Kindred Biosciences KIN Downgrade Neutral
(Buy)
9.23
(9.25)
0.22% Details
5/5/2021 iTeos Therapeutics ITOS New Coverage Buy
(N/A)
23.03
(28.75)
24.84% Details
4/1/2021 EDAP TMS S.A. EDAP Maintain Buy
(N/A)
 
 
  Details
3/2/2021 Ocugen, Inc. OCGN Maintain Buy
(N/A)
 
 
  Details
3/1/2021 ZIOPHARM Oncology ZIOP Downgrade Neutral
(Buy)
5.33
(1.82)
-65.85% Details
2/17/2021 Sesen Bio, Inc SESN Maintain Buy
(N/A)
 
 
  Details
2/10/2021 ALX Oncology ALXO New Coverage Buy
(N/A)
82.18
(77.81)
-5.32% Details
2/4/2021 Ocugen, Inc. OCGN Upgrade Buy
(Neutral)
2.81
(7.93)
182.21% Details
1/21/2021 EDAP TMS S.A. EDAP Maintain Buy
(N/A)
 
 
  Details
1/12/2021 Vericel Corporation VCEL Maintain Buy
(N/A)
 
 
  Details
1/5/2021 Calithera Biosciences CALA Maintain Buy
(N/A)
 
 
  Details
12/18/2020 Surface Oncology SURF Maintain Buy
(N/A)
 
 
  Details
11/27/2020 Corcept Therapeutics CORT Maintain Buy
(N/A)
 
 
  Details
11/17/2020 Diffusion Pharma DFFN Downgrade Neutral
(Buy)
0.66
(0.55)
-16.67% Details
9/10/2020 Trillium Therapeutics TRIL Upgrade Buy
(Neutral)
13.59
(17.34)
27.59% Details
8/27/2020 Personalis PSNL New Coverage Buy
(N/A)
21.88
(22.38)
2.29% Details
7/16/2020 ReWalk Robotics Ltd. RWLK Maintain Buy
(N/A)
 
 
  Details
6/26/2020 Ekso Bionics EKSO Maintain Buy
(N/A)
 
 
  Details
6/24/2020 Precigen Inc. PGEN Maintain Buy
(N/A)
 
 
  Details
6/15/2020 Ekso Bionics EKSO Maintain Buy
(N/A)
 
 
  Details
6/1/2020 Ocugen, Inc. OCGN Downgrade Neutral
(Buy)
0.31
(7.93)
2458.06% Details
6/1/2020 AVEO Pharmaceuticals AVEO Maintain Buy
(N/A)
 
 
  Details
5/28/2020 Mesoblast Limited MESO Maintain Buy
(N/A)
 
 
  Details
5/12/2020 Pulse Biosciences PLSE Upgrade Buy
(Neutral)
11.74
(22.86)
94.72% Details
4/7/2020 Pluristem Therapeutics PSTI Maintain Buy
(N/A)
 
 
  Details
4/3/2020 Collplant Holdings Inc. CLGN Maintain Buy
(N/A)
 
 
  Details
4/1/2020 EDAP TMS S.A. EDAP Maintain Buy
(N/A)
 
 
  Details
3/10/2020 electroCore Inc. ECOR New Coverage Buy
(N/A)
0.65
(0.96)
47.69% Details
3/6/2020 Alphatec Holdings ATEC Maintain Buy
(N/A)
 
 
  Details
3/3/2020 Forty Seven Inc. FTSV Downgrade Neutral
(Buy)
93.91
(95.51)
1.7% Details
2/14/2020 Pulse Biosciences PLSE Downgrade Neutral
(Buy)
12.18
(22.86)
87.68% Details
2/12/2020 IsoRay, Inc. ISR Maintain Buy
(N/A)
 
 
  Details
2/6/2020 Mesoblast Limited MESO Maintain Buy
(N/A)
 
 
  Details
1/7/2020 X4 Pharmaceuticals XFOR New Coverage Buy
(N/A)
10.39
(5.28)
-49.18% Details
12/20/2019 Ocugen, Inc. OCGN New Coverage Buy
(N/A)
0.36
(0.31)
-13.89% Details
12/10/2019 Forty Seven Inc. FTSV Maintain Buy
(N/A)
 
 
  Details
11/19/2019 Calithera Biosciences CALA New Coverage Buy
(N/A)
3.38
(2.27)
-32.84% Details
11/11/2019 Æterna Zentaris AEZS Maintain Buy
(N/A)
 
 
  Details
10/28/2019 Ekso Bionics EKSO New Coverage Buy
(N/A)
0.59
(4.56)
672.88% Details
10/9/2019 Vericel Corporation VCEL New Coverage Buy
(N/A)
13.82
(51.69)
274.02% Details
9/17/2019 Pluristem Therapeutics PSTI Maintain Buy
(N/A)
 
 
  Details
9/12/2019 Tocagen Inc. TOCA Downgrade Neutral
(Buy)
4.18
(1.26)
-69.86% Details
9/11/2019 AVEO Pharmaceuticals AVEO Upgrade Buy
(Neutral)
0.92
(6.89)
648.91% Details
9/6/2019 Corcept Therapeutics CORT New Coverage Buy
(N/A)
12.59
(20.51)
62.91% Details
8/19/2019 Trillium Therapeutics TRIL Downgrade Neutral
(Buy)
0.28
(17.34)
6092.86% Details
8/5/2019 MediWound Ltd MDWD New Coverage Buy
(N/A)
2.59
(3.56)
37.45% Details
6/17/2019 ReWalk Robotics Ltd. RWLK Upgrade Buy
(Neutral)
5.46
(1.35)
-75.27% Details
6/11/2019 Sesen Bio, Inc SESN Upgrade Buy
(Neutral)
2.32
(0.91)
-60.78% Details
6/5/2019 Zomedica ZOM New Coverage Buy
(N/A)
0.29
(0.52)
79.31% Details
5/2/2019 Cellectar Biosciences CLRB New Coverage Buy
(N/A)
2.24
(1.01)
-54.91% Details
3/15/2019 ReWalk Robotics Ltd. RWLK New Coverage Neutral
(N/A)
0.23
(5.46)
2273.91% Details
3/14/2019 Verastem VSTM Maintain Buy
(N/A)
 
 
  Details
3/7/2019 Gritstone Oncology GRTS New Coverage Buy
(N/A)
12.03
(11.50)
-4.41% Details
2/25/2019 Pulse Biosciences PLSE New Coverage Buy
(N/A)
18.23
(12.18)
-33.19% Details
2/1/2019 AVEO Pharmaceuticals AVEO Downgrade Neutral
(Buy)
1.77
(0.92)
-48.02% Details
1/31/2019 Mesoblast Limited MESO New Coverage Buy
(N/A)
4.58
(6.17)
34.72% Details
1/28/2019 IsoRay, Inc. ISR New Coverage Buy
(Neutral)
0.39
(0.68)
74.36% Details
1/4/2019 Sesen Bio, Inc SESN Downgrade Neutral
(Buy)
1.47
(2.32)
57.82% Details
12/24/2018 Histogenics Corp. HSGX Downgrade Neutral
(Buy)
0.47
(0.16)
-65.96% Details
12/18/2018 Advaxis ADXS Downgrade Neutral
(Buy)
0.24
(0.53)
120.83% Details
12/18/2018 Collplant Holdings Inc. CLGN New Coverage Buy
(N/A)
4.10
(16.83)
310.49% Details
11/30/2018 Forty Seven Inc. FTSV New Coverage Buy
(N/A)
18.38
(95.51)
419.64% Details
10/15/2018 Vascular Biogenics Ltd VBLT Upgrade Buy
(Neutral)
1.43
(2.33)
62.94% Details
8/17/2018 Sesen Bio, Inc SESN Maintain Buy
(N/A)
 
 
  Details
8/16/2018 AVEO Pharmaceuticals AVEO New Coverage Buy
(N/A)
2.32
(1.77)
-23.71% Details
8/13/2018 Kindred Biosciences KIN Maintain Buy
(N/A)
 
 
  Details